Dijagnostika infekcije humanim papilomavirusima Vodič za pac...
Cijepljenje protiv HPV infekcije je, uz odgovorno spolno ponašanj...
Objavljeni rezultati cijepljenja u prevenciji genitalnih bradavic...
FDA odobrio cijepljenje muških osoba za prevenciju spolnih bradav...
21% žena u jugoistočnoj Europi s urednim Papa nalazom ima HPV inf...
Nova klasifikacija papiloma virusa razlikuje 189 genotipova
Recommendations on the Use of Quadrivalent HPV Vacci...
Weighing the Benefits and Costs of HPV Vaccination
Preporuke Hrvatskog društva za školsku i sveučilišnu...
Highlights of Prescribing Information
ACIP Provisional Recommend- ations for HPV Vaccine D...
Quadrivalent Human Papillomavirus (Types 6, 11, 16, ...
Molekularni testovi za dokazivanje infekcije HPV-om
Rapid decline in presentations of genital warts afte...
Diagnostic methods and techniques in cervical cancer...
Commercially available assays for multiplex detectio...
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vacc...
Weekly epidemiological record Relevé épidémiologique...
Efficacy Of The Quadrivalent Hpv Vaccine Against Hpv...
Human Papillomavirus and Men - CDS Fact Sheet
Human papillomavirus and HPV vaccines: technical inf...
The HPV (Human Papillomavirus) Immunisation Programm...
Smjernice za uvođenje cjepiva protiv HPV-a u zemlje ...
ECDC Factsheet on HPV Vaccines
HPV and cervical cancer: screening or vaccination?
Eff ect of prophylactic human papillomavirus L1 viru...
Quadrivalent Vaccine against Human Papillomavirus to...
Quadrivalent Human Papilloma-virus Vaccine, Recommen...
High sustained efficacy of a prophylactic quadrivale...
Izrada i održavanje Finder d.o.o.
© 2011 sva prava pridržana
